Status:
TERMINATED
Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients
Lead Sponsor:
Cornea Research Foundation of America
Conditions:
Transplant
Intraocular Pressure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will investigate the use of anecortave acetate injection to reduce intraocular pressure (IOP) in corneal transplant recipients who are experiencing steroid-associated pressure control probl...
Eligibility Criteria
Inclusion
- at least 18 years of age
- corneal transplant recipient with intraocular pressure (IOP) greater than 24 mmHg and with relative increase in IOP of at least 10 mmHg over the pre-graft baseline
Exclusion
- not pregnant or lactating
- intraocular surgery in the study eye within 30 days before enrolling in the study
- use of any investigational drug or treatment within 30 days before receipt of study medication
- clinical evidence of scleral thinning
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00884039
Start Date
May 1 2009
End Date
September 1 2010
Last Update
August 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Price Vision Group
Indianapolis, Indiana, United States, 46260